Furthermore, elevated expression of both PRMT5 and cofactor MEP50 is strongly correlated with poorer prognosis in lung cancer patients from a public clinical database (http://www.kmplot.com) (Figure S5B,C, Supporting Information). This evidence concerns the gene PRMT5 and lung carcinoma.